Assessing Neutrophil CD64 Expression: A Key Biomarker for Diagnosing Infections and Evaluating Antibiotic Therapy in Acute Leukemia Patients
نویسندگان
1 Department of Hematology and Blood Transfusion, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
2 Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. - Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
3 Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran - Department of Medical Oncology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
4 Department of Hematology and Blood Transfusion, School of Allied Medical Sciences, Tehran University of Medical sciences, Tehran, Iran
doi
10.61186/ijbc.16.3.23چکیده
Introduction: Patients with acute leukemia (AL) are at an increased risk of infection, particularly in acute or critical situations, where timely identification of the cause of infection is crucial. While traditional methods such as microbial cultures remain the gold standard, they require 24–48 hours for results. In recent years, novel ...
